Policy | Behavioral Healthcare Executive Skip to content Skip to navigation


'Heartless' Senate bill slashes Medicaid, offers $2 billion in opioid funds

June 22, 2017  |  Julie Miller, Editor in Chief

President Trump said the Senate bill should have more “heart,” but industry experts reviewing the draft after its release today don’t believe it contains any heart at all. For one, the bill would end Medicaid expansion in 2020.

Insurers not providing sufficient evidence of parity act compliance

June 22, 2017  |  Tom Valentino, Senior Editor

A recently analysis finds insurers are not providing consumers or state regulators with adequate documentation about their plans’ mental health and addiction treatment benefits.

New bipartisan bill revisits IMD issue

June 7, 2017  |  Julie Miller, Editor in Chief

The Medicaid Coverage for Addiction Recovery Expansion (CARE) Act would allow Medicaid payment to residential addiction treatment facilities with up to 40 beds—an increase over the current 16 bed limit. It would also allow for treatment services for up to...

Need for buprenorphine demonstrated in Medicaid data

June 7, 2017  |  Julie Miller, Editor in Chief

A new brief from the Urban Institute shows that Medicaid programs nationwide have seen increases in buprenorphine prescriptions since the launch of the Affordable Care Act, but trends are higher in expansion states.

Rumored gutting of ONDCP agenda does not materialize in president's budget plan

May 24, 2017  |  Gary A. Enos, Contributing Editor

Most core functions of the Office of National Drug Control Policy, including oversight of the Drug-Free Communities Support Program, are preserved in President Trump's fiscal 2018 budget proposal.

The US Senate can improve health reform

May 12, 2017  |  Ron Manderscheid, PhD, Exec Dir, NACBHDD and NARMH

The behavioral health community is dismayed by the recent vote in the House to approve the American Health Care Act (AHCA). We hope that considerably more reasonable decisions will prevail in the Senate.

Is the American Health Care Act rising from the dead?

May 3, 2017  |  Walter H. Boone

What does the rise of the American Health Care Act and the MacArthur Amendment mean for the alcohol and drug treatment industry?

Will you join us in this Herculean effort?

May 1, 2017  |  Ron Manderscheid, PhD, Executive Director, NACBHDD and NARMH

Federal officials are choosing deliberately to make it more difficult and more costly for those with pre-existing conditions, those with disabilities, and those who are older to access necessary healthcare. We must work immediately to defeat AHCA.

Why you need to be concerned about the next drug czar

April 12, 2017  |  Julie Miller, Editor in Chief

Behavioral healthcare stakeholders might have a reason to drop what they’re doing—right now—and get on the phone to anyone in Washington who will listen.

NatCon17: U.S. health system lacks value

April 6, 2017  |  Julie Miller, Editor in Chief

The U.S. system splits consumers into narrow categories, and that fragmentation alone has led to a significant amount of waste, according to Uwe Reinhardt speaking at the National Council for Behavioral Health annual conference this week.

New Jersey progress could inspire national agenda

April 1, 2017  |  Julie Miller, Editor in Chief

Governor Chris Christie is leading the White House commission's effort, and he has a long track record of driving treatment-focused solutions in New Jersey.

Trump names ONDCP acting director

March 29, 2017  |  Julie Miller, Editor in Chief

The White House named Richard Baum as acting director of the Office of National Drug Control Policy.


Subscribe to Policy